Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Southern First Bancshares
SFST
$607M
| $651K | ﹤0.01% |
20,510
| – | – |
|
|
OPRA
2927
Opera Ltd
OPRA
$1.84B
| $650K | ﹤0.01% |
41,085
+22,294
| +119% | +$282K |
|
2928
Bel Fuse Inc Class A
BELFA
$3.44B
| $649K | ﹤0.01% |
9,170
+235
| +3% | +$15.8K |
|
2929
HEICO Corp Class A
HEI.A
$37.2B
| $648K | ﹤0.01% |
4,210
+1,232
| +41% | +$182K |
|
2930
AerSale
ASLE
$308M
| $646K | ﹤0.01% |
89,907
+18,002
| +25% | +$166K |
|
2931
Pearson
PSO
$9.95B
| $644K | ﹤0.01% |
48,915
+9,525
| +24% | +$118K |
|
2932
Bridgewater Bancshares
BWB
$584M
| $644K | ﹤0.01% |
55,290
| – | – |
|
2933
Philips
PHG
$25.9B
| $642K | ﹤0.01% |
35,885
+7,480
| +26% | +$143K |
|
2934
First Bancorp
FNLC
$401M
| $640K | ﹤0.01% |
25,964
| – | – |
|
|
EBTC
2935
DELISTED
Enterprise Bancorp
EBTC
| $639K | ﹤0.01% |
24,600
-1,164
| -5% | -$32.2K |
|
2936
FS Bancorp
FSBW
$319M
| $636K | ﹤0.01% |
18,326
| – | – |
|
2937
Century Therapeutics
IPSC
$364M
| $636K | ﹤0.01% |
152,051
+3,290
| +2% | +$13.9K |
|
2938
Civista Bancshares
CIVB
$604M
| $633K | ﹤0.01% |
41,185
| – | – |
|
2939
Village Super Market
VLGEA
$656M
| $631K | ﹤0.01% |
22,051
-1,011
| -4% | -$26.6K |
|
2940
Larimar Therapeutics
LRMR
$425M
| $630K | ﹤0.01% |
83,009
+9,246
| +13% | +$72K |
|
2941
Red River Bancshares
RRBI
$670M
| $629K | ﹤0.01% |
12,641
-350
| -3% | -$17.8K |
|
|
KYNB
2942
Kyntra Bio
KYNB
$28.2M
| $628K | ﹤0.01% |
10,687
+2,321
| +28% | +$100K |
|
2943
Legacy Housing
LEGH
$649M
| $627K | ﹤0.01% |
29,139
+1,675
| +6% | +$40.2K |
|
2944
Equinor
EQNR
$93B
| $626K | ﹤0.01% |
23,164
-5,469
| -19% | -$150K |
|
|
NVEI
2945
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $623K | ﹤0.01% |
19,695
+7,200
| +58% | +$182K |
|
2946
Vodafone
VOD
$36.3B
| $622K | ﹤0.01% |
69,915
+26,907
| +63% | +$234K |
|
2947
Acacia Research
ACTG
$447M
| $621K | ﹤0.01% |
116,573
| – | – |
|
2948
LivePerson
LPSN
$27.1M
| $616K | ﹤0.01% |
41,147
+3,139
| +8% | +$108K |
|
2949
Park-Ohio Holdings
PKOH
$594M
| $614K | ﹤0.01% |
23,018
-1,217
| -5% | -$30.9K |
|
|
ZYXI
2950
DELISTED
Zynex
ZYXI
| $614K | ﹤0.01% |
49,634
-75,538
| -60% | -$906K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.